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Introductions: Vasculitides can cause significant morbidity and 
mortality if not treated on time. There is lack of data locally. This 
study aim to define the pattern, clinical characteristics, and outcome 
of vasculitides. 
 
Methods: This was a cross sectional study  between January 2011 to 
December 2015 at Patan Hospital, Patan Academy of Health 
Sciences, Lalitpur, Nepal. The medical records of patients diagnosed 
with vasculitides in adults rheumatology service of the hospital were 
reviewed. 
 
Results: Ninety six patients were diagnosed with vasculitides during 
the study period. The mean age was 42.2 years. Sixty nine (71.8%) 
patient had small vessel, 20 (20.8%) large vessel and five (5.2%) had 
variable vessel vasculitides. Seventy five patients (78.1%) had 
primary and 21 (21.8%) secondary vasculitides. Cutaneous 
leucocytoclasticangitis was seen in 27 (28.1%), Takayasu arteritis in 
17 (17.7), Henoch-Schonlein purpure in 11 (11.4%) and Rheumatoid 
arthritis associated vasculitis in nine patients. Purpura was present in 
all 96 (100%). The overall mortality was 9 (9.3%).  
 
Conclusions: Primary vasculitides were more common than 
secondary forms. Small vessel vasculitis was the most common. 
Cutaneous symptoms were predominant features. The mortality was 
attributed to active disease, sepsis, and complications of the primary 
disease.  
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Vasculitides are a heterogeneous group of 
diseases defined by the presence of 
inflammatory infiltrates in the blood vessel 
walls. Spread over several entities, these are 
rare but important clinical conditions. Timely 
identification and treatement can significantly 
decrease the associated morbidity and 
mortality.1 
 
Epidemiological data on vasculitides are mostly 
from Western countries. In Europe, the annual 
incidence of primary systemic vasculitides is 
approximately 20 per million population.2 
Studies have showed that vasculitides are 
common in elderly; however, the prevalence 
differs in different populations. In Western 
Nepal, only one case of vasculitis was observed 
in a series of 365 rheumatic cases.3 
 
Exception few case reports and small series4,5 
on vasculitis, there is lack of data on clinical 
presentation and outcome locally. This study 
aim to assess clinical characteristics and 
outcome of vasculitic diseases from a tertiary 




This was a cross sectional study conducted at 
Patan Hospital, Patan Academy of Health 
Sciences (PAHS), Kathmandu, Nepal. The 
medical records of patients diagnosed with 
vasculitides in the adult rheumatology service 
(medical outpatient and different wards) of 
Patan Hospital from 1st January 2011 to 31st 
December 2015 were reviewed. Patient’s 
demographic data and clinical information on 
type and subtype of vasculitides, presentation, 
laboratory, imaging and biopsy, treatment, and 
outcome until the last follow up of few days to 
a maximum of 4 years were recorded. 
Investigations and imaging studies included 
were: rheumatoid factor (RF), antinuclear 
antibody (ANA), anti-double stranded  
deoxyribonucleic acid (anti-dsDNA) antibodies, 
antineutrophil cytoplasmic antibodies (c-ANCA 
& p-ANCA), serological tests for hepatitis B, 
hepatitis C,human immunodeficiency virus 
(HIV), and angiogram of the aorta/ affected 
blood vessels in selected patients. Children 
below 14 years of age were excluded. For 
primary vasculitides, the diagnosis was based 
on American College of Rheumatology (ACR) 
1990 vasculitis classification criteria6 and 
Chapel Hill Consensus Conference 1992 
vasculitis nomenclature system.7 For 
secondary vasculitides, diagnosis was based on 
clinical manifestations supported by 
appropriate investigations. Patients were 
treated according to the standard treatment 
protocol for that particular type of vasculitis8, 9 
and followed up every 3 to 6 months. Outcome 
at last follow up was recorded. A broad 
outcome measure which is also used for 
childhood systemic lupus erythematosus, was 
used.10 The outcome was grouped as remission 
on treatment, active disease despite 
treatment, lost to follow up, and death. The 
death at home or other health facility was 
confirmed by interrogating with family 
members or relatives. Ethical approval was 
taken from Institutional Review Committee of 





There were 96 patients diagnosed with 
vasculitides during the study period. Mean age 
was 42.2 years (range 18-78). Female to male 
ratio was 2:1. Sixty nine (71.8%) patients had 
small vessel, 20 (20.8%) large vessel, five 
(5.2%) variable vessel and two (2%) had 
medium vessel involvement. Primary 
vasculitides was present in 75 (78.1%) and 
secondary in 21(21.9%),(Table 1). Clinical 
manifestations of vsaculitis presented 
varyingly, Table 2. 
 
The outcome xwas good in 37 (38.5%) cases, 
(Table 3). In primary vasculitides, one (1%) 
case each of Takayasu arteritis and Wegener’s 
granulomatosis, and one (1%) case each of 
polyarteritis nodosa and microscopic 
polyangiitis died. Among secondary 
vasculitides, all two (2%) cases of malignancy 
associated and one (1%) case of lupus 
associated mesenteric vasculitis died. 
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 Table 1. Frequency distribution of vasculitic disorders at Patan Hospital 
 
 
Type Male Female Mean age y 
Large vessel vasculitis (n= 
20) 
Takayasu arteritis (17) 2 15 30.71 
Gaint cell arteritis (3) 1 2 71.33 
Medium vessel vasculitis 
(n= 2) 








Wegener’s granulomatosis or 
granulomatosis with polyangiitis (7) 
3 4 55.29 
Churg-Strauss syndrome (2) 1 1 41 
Microscopic polyangiitis (1) 1 0 57 
Henoch-Schonlein purpura or IgA vasculitis 
(11) 
6 5 32.45 
Cutaneous leucocytoclastic angiitis (27) 9 18 43.3 
Secondary 
(21) 
Rheumatoid arthritis associated (9) 2 7 58.11 
Systemic lupus erythematosus associated 
(6) 
0 6 27.83 
Malignancy associated (2) 2 0 66.5 
Drug associated (4) 3 1 43.75 
Variable vessel vasculitis 
(n=5) 
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Table 2. Common manifestations of some forms of vasculitides 
 
 
Note: *Eye inflammation: scleritis, keratitis, proptosis, scleromalacia; † Nasal/paranasal symptoms: sinusitis, 
epistaxis, nasal septum perforation, nasal crusts;‡ Renal symptoms: haematuria, proteinuria, elevated 






Diagnostic category (n) Presenting features Number (%) 
Takayasu arteritis (17) Loss of pulses 16(94%) 
 Arthritis/arthralgia/myalgia 16 (94%) 
 Fever 8 (47%) 
 Hypertension 8 (47%) 
 Headache 4 (24%) 
 Stroke 2 (12%) 
Wegener’s granulomatosis (7) 
 
Eye inflammation* 6 (86%) 
 Arthritis/arthralgia/myalgia 6 (86%) 
 Nasal/Paranasal symptoms † 5 (71%) 
 Fever 5 (71%) 
 Renal manifestations ‡ 5 (71%) 
 Pulmonary features § 5 (71%) 
 Neuropathy 5 (71%) 
 Purpura 2 (29%) 
Henoch-Schonlein purpura (11) Purpura 11 (100%) 
 Arthritis/arthralgia/myalgia 11 (100%) 
 Abd. Pain/GI bleeding 5 (45%) 
 Renal manifestations ‡ 4 (36%) 
Cutaneous leucocytoclastic angiitis (27) Purpura 27 (100%) 
 Arthritis/arthralgia/myalgia 10 (37%) 
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Disease remission while on 
treatment 
37 (39%) 
Active Disease despite treatment 15 (16%) 
Lost to follow up 35 (36%) 





In this study mean age of the patients with 
vasculitis was 42 years. Vasculitis, being a 
broad constellation of disorders, is a disease of 
all age groups.  Different forms of vasculitides 
have different age predilection. Primary 
vasculitides like Takayasu arteritis and Henoch-
Schonlein purpura are more common in young 
age group whereas most of the other forms of 
primary systemic vasculitides particularly Giant 
cell arteritis are more common with advancing 
age.11 The relative lower mean age in this 
series could be due to predominance of 
Takayasu arteritis, cutaneous leucocytoclastic 
angiitis and Henoch-Schonlein purpura which 
are all more common in young age group and 
at the same time relative rarity of other forms 
of primary vasculitides which are more often 
seen in elderly.  
 
There was female predominance (male:female 
ratio of 1:2), and more so for diseases like 
Takayasu arteritis, cutaneous leucocytoclastic 
angiitis, and secondary vasculitides associated 
with autoimmune diseases like RA and SLE. 
Similar female predominance in different types 
of vasculitides is reported from India.12, 13 In 
this study, primary vasculitis was much more 
common than secondary vasculitis in general, 
78% versus 22% respectively  in both sexes.  
 
The most common form of vasculitis in our 
study was cutaneous leucocytoclastic angiitis, 
followed by Takayasu arteritis, Henoch-
Schonlein purpura, and RA associated 
secondary vasculitis. Cutaneous vasculitis was 
also a predominant form of vascultis in studies 
from Western India13 and Denmark.14 The 
relative excess of Takayasu arteritis over other 
primary vasculitides may be due to the fact 
that this disease is more prevalent in Asian 
countries.15 Henoch-Schonlein purpura is 
predominantly a disease of childhood; 
however, several studies have observed that 
this disease also comprises significant 
proportion of vasculitis in adult population.6,12 
Other forms of systemic vasculitides, 
particularly Giant cell arteritis, Polyarteritis 
nodosa, Churg-Strauss syndrome, and 
Microscopic polyangiitis were less common as 
in other series.12,16 Behcet’s disease, which can 
affect veins in preference to arteries and can 
affect all sizes of blood vessels, was observed 
in five patients (5.2%). The relative rarity of 
Behcet’s disease in our series as compared to 
Indian12 and Iranian studies16 could either be 
due to rarity of this disease in our population 
or due to lack of referral to rheumatology 
service.  
 
Takayasu arteritis often causes granulomatous 
inflammation of the aorta and/or its major 
branches and more often begins before the 
age of 50 years.17 The most common way of 
presentation in our population was muscle and 
joint pain and lack of pulses on 
physicalexamination which were present in 
94% of cases. Approximately half (47%) 
presented with hypertension, whereas 2 cases 
developed stroke as a complication of the 
disease. Takayasu arteritis is the commonest 
cause of renovascular hypertension in India 18, 
so early identification and treatment to 
optimal level is essential to avoid 
complications of hypertension like stroke and 
myocardial ischaemia.  
 
Many cases of Wegener’s granulomatosis in 
our series had diffuse disease and presented 
with multisystem involvement including 
kidneys. One patient underwent renal 
transplantation for end stage kidney disease. 
Relapse of disease was seen in 3 cases; one 
patient had multiple relapses. She had bilateral 
parotid enlargement as part of relapse before 
she died of severe sepsis. Though ours was a 
small series and not directly comparable with 
data from larger series, the relapse in treated 
Wegener’s granulomatosis is as high as 57%.19 
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Both Henoch-Schonlein purpura and 
cutaneous leucocytoclastic angiitis presented 
with purpuric rashes in 100% of cases. In 
Henoch-Schonlein purpura, renal involvement 
in the form of haematuria and proteinuria was 
observed in almost half of patients whereas 
gastrointestinal involvement was seen in 36% 
of cases. Several other studies have also 
highlighted that Henoch-Schonlein purpura is 
more severe in adults particularly with renal 
involvement.20 
 
As we were dealing with several different 
types of vasculitides, we used a broad 
outcome measure which has also been used 
for childhood systemic lupus erythematosus10. 
More than one third of our patients lost to 
follow up. It appeared that many patients with 
milder forms of disease particularly cutaneous 
vasculitides lost to follow up. Nine patients 
died in this series; 2 from Wegener’s 
granulomatosis, Takayasu arteritis and 
malignancy associated secondary vasculitis 
each, and one each from Polyarteritis nodosa, 
SLE and Microscopic polyangiitis. In Wegener’s 
granulomatosis, one patient died of active 
disease whereas another succumbed to severe 
sepsis. In Takayasu arteritis, one patient died 
due to acute left ventricular failure due to 
uncontrolled hypertension, whereas the cause 
of death was not clear in the second case who 
died at home. In malignancy associated 
vasculitis, the cause of death was terminal 
cancer. In all other cases, the death was due to 
active vasculitis.  
 
As different forms of vasculitides can present 
with different manifestations to different 
subspecialists, only patients seen in 
rheumatology service were included in this 
study. Thus some form of vasculitides like 
renal-limited vasculitis and primary central 
nervous system vasculitis could have been 
missed whereas others like Behcet’s disease 
could have been underrepresented. Similarly 
as this study was conducted in patients older 
than 14 years of age, vasculitis presenting 
exclusively in childhood, particularly Kawasaki 
disease was not observed in this study. 
 
Through this study we have tried to provide a 
bird’s eye view of vasculitis scenario from a 
hospital in central Nepal. Being a single centre 
report of retrospective design and with small 
sample size, this study may not reflect the true 
picture of the extent and problem of 
vasculitides in Nepal. Nevertheless, we believe 
that this study will open up avenues for future 
research and on that ground more 
comprehensive vasculitis database and 






Primary vasculitides were more common than 
secondary forms of vasculitides in general and 
in both the sexes. Small vessel vasculitis was 
the most commonly observed form of 
vasculitides; cutaneous leucocytoclastic 
angiitis, Henoch-Schonlein purpura, and 
autoimmune disease associated secondary 
vasculitides were more frequent 
presentations. Purpura was the most frequent 
presentation in cutaneous leucocytoclastic 
angiitis and Henoch-Schonlein purpura 
whereas other forms of vasculitides presented 
with multisystem involvement. The overall 
mortality rate of 9% was attributed to active 
disease, sepsis, and complications of the 
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